Breaking news

Strategic Merger Transforms Cyprus Banking Landscape With the Launch of Eurobank

New Era In Cyprus Banking

Two of the most influential financial institutions in Cyprus have united in a long-planned strategic merger that combines decades of expertise and a celebrated history. The integration of the Hellenic Bank with Eurobank Cyprus has reshaped the nation’s financial landscape while expanding its influence throughout the region.

Building A Formidable Financial Powerhouse

Rebranded as Eurobank, the newly merged entity is set to become Cyprus’s largest and most robust banking institution. With enhanced capital reserves and an elevated market position, Eurobank is uniquely positioned to act as a gateway for companies looking to invest in emerging markets. This innovative merger melds the established local presence of the Hellenic Bank with the expansive international reach of Eurobank, delivering a comprehensive suite of competitive financial services.

A Bold Investment In Cyprus’s Future

The Eurobank Group’s groundbreaking €1.3 billion investment in Cyprus demonstrates its strong confidence in the island’s role as a regional financial and investment hub. After extensive research and deliberations, the name Eurobank was chosen to signal a new era of reliability and trust in the market. While the institution’s name, scale, and capabilities evolve, its unwavering commitment to client service, innovation, and security remains intact.

Impressive Financial Foundations

Eurobank’s robust financial metrics underscore its strength. The institution reports €27 billion in total assets—including loans, cash, investments, and real estate—€8.6 billion in loans, and €23 billion in deposits. With a commanding 42% market share in deposits and 36% in loans, the bank has also contributed over €61.5 million in taxes and social contributions in 2024 while employing more than 3,000 people, underscoring its vital economic role.

A Seamless Transition For Clients

The integration process is progressing in well-defined stages, with full legal unification scheduled for early July. Throughout this transition, ensuring uninterrupted support for clients remains a top priority. Essential banking credentials, such as account numbers, IBANs, card PINs, and online banking details, will remain unchanged. Combined branch operations will eventually offer enhanced convenience, while current in-branch services continue without disruption.

Looking Ahead: Resilience And Innovation

The creation of Cyprus’s most powerful bank marks a significant milestone that blends local expertise with international know-how. Eurobank is set to provide an enriched banking experience—featuring an expansive branch network, innovative banking solutions, and enhanced digital capabilities—geared toward meeting the evolving needs of businesses and households in an ever-changing economic landscape.

Colossal Biosciences Seeks Funding At Up To $30 Billion Valuation

Colossal Biosciences, the biotechnology startup known for its efforts to revive extinct species including the woolly mammoth and dire wolf, is in talks to raise funding at a valuation of $20 billion to $30 billion, according to Axios.

The company was last valued at $10.2 billion in a January funding round. It has since begun generating revenue, Axios reported, although neither the size of the new financing nor its potential investors have been disclosed.

Business Extends Beyond De-Extinction

While Colossal has attracted global attention for its de-extinction projects, the company is also building a broader biotechnology business around the tools developed through that research.

Co-founder and Chief Executive Ben Lamm has said Colossal expects revenue from three areas: conservation technologies, new businesses created from its research and future commercial applications of technologies developed alongside its de-extinction programme.

Expanding Commercial Portfolio

Colossal has already supplied conservation technology to the U.S. government and the United Arab Emirates, which recently invested $60 million in the company, according to Wired.

Its research has also led to the creation of several startups, including plastics recycling company Breaking, computational biology platform Form Bio, which raised $30 million, and AI-driven biology company Astromech, which was valued at $2 billion in March.

Research Continues To Expand

Operating from a 55,000-square-foot facility in Dallas, Colossal continues to broaden its research portfolio.

In April, the company added the bluebuck antelope as its sixth de-extinction target. More recently, the Colossal Foundation partnered with the University of Tasmania to develop vaccines and gene-editing approaches aimed at protecting Tasmanian devils from a contagious facial cancer.

Lamm has also said the company plans to spin out its artificial womb technology, which could eventually have applications in fertility treatment. Speaking to Rolling Stone in May, he said the technology could be ready next year.

Investor Interest In Deep Tech

The fundraising discussions come as investors increase spending on sectors such as biotechnology, longevity and other deep-tech fields.

Lamm has also said Colossal could eventually generate revenue from biodiversity credits if restored species are successfully reintroduced into their natural habitats, creating another potential commercial opportunity.

eCredo
Aretilaw firm
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter